Company / Cash & Equivalents
Aveanna Healthcare Holdings, Inc. Cash & Equivalents History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$84.3M
FY2024
5-year range
$19.2M / $137.3M
FY2020-FY2024
Trend
+91.8%
vs FY2023
Sector context
#120 of 152
Health Care
What the data says
Aveanna Healthcare Holdings, Inc.'s cash & equivalents of $84M is lower than 79% of companies in the Health Care sector (FY2024). Improved from $19M to $84M over the past 2 years.
Based on SEC 10-K filings.
$84M in FY2024 with a 3-year CAGR of +40.3%.
Improved from $19M to $84M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +40.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 152This company $84.3M Sector average $1.2B
▼
-92.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +40.3%, indicating consistent growth.
- In FY2024, cash & equivalents increased 91.8% year-over-year.
- Ranks #120 out of 152 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $84.3M | +91.8% |
| FY2023 | $43.9M | +128.7% |
| FY2022 | $19.2M | -37.0% |
| FY2021 | $30.5M | -77.8% |
| FY2020 | $137.3M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026